Bidirectional Mendelian Randomization identifies plasma proteins associated with Cervical Cancer risk
Abstract
Background
Cervical
cancer
continues
to
pose
a
considerable
challenge
global
health,
necessitating
innovative
approaches
for
improved
diagnostics
and
personalized
treatment
strategies.
Prior
investigations
have
suggested
that
plasma
proteins
may
play
role
in
the
pathogenesis
of
cervical
cancer;
however,
these
studies
do
not
confirm
causal
relationship.
To
address
this
gap,
conducted
large-scale
Mendelian
randomization
(MR)
study
proteome.
Methods
We
two-sample
bidirectional
analysis
4,907
using
publicly
available
genome-wide
association
(GWAS)
summary
statistics
investigate
relationship
between
proteome
risk.
Analytical
methods
included
inverse
variance
weighting
(IVW),
weighted
median,
MR-Egger
regression,
simple
models.
Additionally,
we
performed
sensitivity
analyses
evaluate
heterogeneity
horizontal
pleiotropy
through
Cochran's
Q
test,
intercept,
MR-PRESSO
leave-one-out
analysis.
also
applied
false
discovery
rate
(FDR)
correction
results
all
(IVW)
identify
most
strongly
associated
with
cancer.
Finally,
enriched
relevant
protein
genes
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
Gene
Ontology
(GO)
GeneMANIA
disease-related
pathways.
Results
According
IVW
method,
seven
are
significantly
risk
(FDR-adjusted
p
<
0.05).
Specifically,
six
demonstrated
protective
factors:
DEFB135
(OR
=
0.201,
95%
CI
0.082–0.492,
p
0.001),
FGL2
0.104,
0.032–0.338,
FTMT
0.612,
0.465–0.804,
PDIA4
0.088,
0.026–0.295,
SPHK2
0.102,
0.030–0.350,
TMED2
0.045,
0.008–0.246,
0.001).
In
contrast,
RACGAP1
1.755,
1.286–2.395,
0.001)
was
identified
as
factor.
Reverse
MR
revealed
no
significant
evidence
reverse
causation
(p
>
0.05)
proteins.
Functional
enrichment
several
biologically
pathways
potentially
involved
pathogenesis,
including
establishment
organelle
localization,
regulation
oxidoreductase
activity,
Ferroptosis,
Porphyrin
metabolism.
Conclusion
These
findings
suggest
DEFB135,
FGL2,
FTMT,
PDIA4,
SPHK2,
protect
against
cancer,
while
represent
potential
The
tumor
markers
provide
mechanistic
insights
into
molecular
basis
warrant
further
investigation
functional
studies.
Published: May 13, 2025
Language: Английский